Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
CNY 9.37
(-0.85%)
CNY 9.37
(-0.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 46.12 Million | -78.37 Million | 508.83 Million | 174.47 Million | 246.76 Million | 191.83 Million |
| Net Income | 44.23 Million | -71.92 Million | 329.76 Million | 253.59 Million | 182.92 Million | 95.53 Million |
| Depreciation & Amortization | 185.88 Million | 160.44 Million | 154.96 Million | 126.22 Million | 108.97 Million | 84.67 Million |
| Deferred income taxes | -594.28 Thousand | -6.73 Million | -8.91 Million | -678.1 Thousand | 2.01 Million | -2.03 Million |
| Stock-based compensation | - | 4.14 Million | - | 2.72 Million | - | - |
| Change in working capital | -311.3 Million | -417.27 Million | -75.4 Million | -283.26 Million | -166.78 Million | -55.07 Million |
| Other non-cash items | 811.01 Million | 252.96 Million | 99.51 Million | 75.86 Million | 121.66 Million | 66.69 Million |
| Investing Cash Flow | -255.56 Million | -332.21 Million | -282.28 Million | -311.76 Million | -132.14 Million | -931.57 Million |
| Investments in PPE | -266.22 Million | -472.18 Million | -303.87 Million | -153.16 Million | -133.27 Million | -162.4 Million |
| Acquisitions | 18.88 Million | 30.92 Million | -21.71 Million | 14.01 Million | 134.6 Million | -782.21 Million |
| Investment purchases | -94.09 Million | -56 Million | -32.02 Million | -80.73 Million | -2 Million | -2 Million |
| Sales/Maturities of investments | 85.87 Million | 95.49 Million | 1.98 Million | 37.08 Million | 1.8 Million | 1.8 Million |
| Other Investing Activities | -20 Thousand | 69.54 Million | 73.35 Million | -128.95 Million | -133.27 Million | 13.24 Million |
| Financing Cash Flow | 83.01 Million | 363.58 Million | -301.78 Million | 537.75 Million | 72.51 Million | 704.29 Million |
| Debt repayment | -152.08 Million | -1.14 Billion | -1.28 Billion | -1.46 Billion | -1.17 Billion | -742.52 Million |
| Dividends payments | -68.25 Million | -122.43 Million | -122.43 Million | -58.67 Million | -35.92 Million | -108.39 Million |
| Common Stock Repurchased | -10.18 Million | -2.84 Million | -1.4 Million | - | -7.14 Million | - |
| Common Stock Issuance | - | 2.84 Million | 1.4 Million | - | 7.14 Million | - |
| Other Financing Activities | 315.27 Million | 1.72 Billion | 1.18 Billion | 2.15 Billion | 1.36 Billion | 1.55 Billion |
| Accounts receivables | 160.47 Million | -187.87 Million | -349.61 Million | -131.98 Million | -146.57 Million | -120.32 Million |
| Accounts payables | -5.96 Million | 58.92 Million | 292.64 Million | 52.03 Million | 45.88 Million | 117.18 Million |
| Inventory | -465.85 Million | -281.59 Million | -9.52 Million | -202.63 Million | -68.11 Million | -49.91 Million |
| Other working capital | 39.72 Thousand | -6.73 Million | -8.91 Million | -678.1 Thousand | 2.01 Million | -5.16 Million |
| Cash at beginning of period | 661.56 Million | 614.26 Million | 689.25 Million | 294.27 Million | 108.6 Million | 141.25 Million |
| Cash at end of period | 565.13 Million | 578.76 Million | 614.26 Million | 689.25 Million | 294.27 Million | 108.6 Million |
| Capital Expenditure | -266.22 Million | -472.18 Million | -303.87 Million | -153.16 Million | -133.27 Million | -162.4 Million |
| Effect of forex changes on cash | 815.37 Thousand | 11.5 Million | 236.45 Thousand | -5.49 Million | -1.45 Million | 2.78 Million |
| Net cash flow / Change in cash | -96.42 Million | -35.49 Million | -74.99 Million | 394.97 Million | 185.67 Million | -32.65 Million |
| Free Cash Flow | -220.09 Million | -550.55 Million | 204.96 Million | 21.31 Million | 113.49 Million | 29.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.92 Million | 10.61 Million | 12.28 Million | 44.23 Million | 4.91 Million | 4.04 Million |
| Depreciation & Amortization | - | 56.27 Million | 56.27 Million | 185.88 Million | 48.6 Million | 48.6 Million |
| Deferred income taxes | - | - | - | -594.28 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -311.3 Million | -305.33 Million | - |
| Other non-cash items | -9.57 Million | -28.85 Million | 79.8 Million | 811.01 Million | 36.72 Million | 91.36 Million |
| Investing Cash Flow | -146.1 Million | -56.96 Million | -96.58 Million | -255.56 Million | -29.37 Million | -39.02 Million |
| Investments in PPE | -135.3 Million | -56.46 Million | -96.58 Million | -266.22 Million | -51.89 Million | -49.02 Million |
| Acquisitions | - | - | - | 18.88 Million | 12.73 Million | - |
| Investment purchases | -10.8 Million | -500 Thousand | - | -94.09 Million | -66.09 Million | - |
| Sales/Maturities of investments | - | - | - | 85.87 Million | 75.87 Million | 10 Million |
| Other Investing Activities | - | -500 Thousand | - | -20 Thousand | 22.51 Million | - |
| Financing Cash Flow | -410.16 Million | 738.88 Million | 14.63 Million | 83.01 Million | -192.92 Million | 234.62 Million |
| Debt repayment | -375.41 Million | -240.62 Million | -108.42 Million | -152.08 Million | -333.27 Million | -424.6 Million |
| Dividends payments | - | -28.65 Million | -23.79 Million | -68.25 Million | -68.25 Million | -22.69 Million |
| Common Stock Repurchased | - | - | - | -10.18 Million | -10.18 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -34.74 Million | 971.46 Million | -93.79 Million | 315.27 Million | 220.51 Million | 681.93 Million |
| Accounts receivables | - | - | - | 160.47 Million | 160.47 Million | - |
| Accounts payables | - | - | - | -5.96 Million | - | - |
| Inventory | - | - | - | -465.85 Million | -465.85 Million | - |
| Other working capital | - | - | - | 39.72 Thousand | 39.72 Thousand | - |
| Cash at beginning of period | 1.15 Billion | 522.96 Million | 565.13 Million | 661.56 Million | 803.99 Million | 395.02 Million |
| Cash at end of period | 686.22 Million | 1.15 Billion | 522.96 Million | 565.13 Million | 565.13 Million | 685.7 Million |
| Capital Expenditure | -135.3 Million | -56.46 Million | -96.58 Million | -266.22 Million | -51.89 Million | -49.02 Million |
| Effect of forex changes on cash | - | -310.55 Thousand | -931.08 Thousand | 815.37 Thousand | -3.27 Million | -337.13 Thousand |
| Net cash flow / Change in cash | -470.96 Million | 634.22 Million | -42.17 Million | -96.42 Million | -238.85 Million | 290.67 Million |
| Free Cash Flow | -158.8 Million | -130.97 Million | -4.49 Million | -220.09 Million | -58.85 Million | 46.38 Million |
UNIOFFICE
PSTO
AXREF
INTEGHIT
605577
006060